{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T20:36:58Z","timestamp":1776976618269,"version":"3.51.4"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/cc-by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>To determine the association between soluble FMS-like tyrosine kinase-1 (sFlt-1) and high-sensitivity C-reactive protein (hs-CRP) with maternal and perinatal outcomes in patients with preeclampsia (PE) with severe features.<\/jats:p>\n            <jats:p>A cohort study was conducted on 100 patients, 60 with PE with severe features, and 40 healthy women in the third trimester of pregnancy. Admission serum levels of sFlt-1 and hs-CRP and clinical and epidemiological parameters were evaluated to quantify the predictive ability of adverse maternal and perinatal outcomes using hierarchical multiple regression and receiver operating characteristic curves.<\/jats:p>\n            <jats:p>Compared to controls, patients with PE and severe features had significantly higher levels of sFlt-1 but not hs-CRP. sFlt-1 and hs-CRP proved to be reasonable parameters for the prediction of composite adverse maternal outcomes. However, we found no correlation between these 2 biomarkers. PE integrated estimate of risk scores were correlated only with sFlt-1 levels. Regarding fetal outcomes, unlike hs-CRP, sFlt-1 was strongly associated with birth weight and Apgar score &lt; 7 at 5 minutes. Following multivariate analysis, maternal age, previous hypertension, sFlt-1, and hs-CRP levels remained independently associated with composite adverse maternal outcomes.<\/jats:p>\n            <jats:p>sFlt-1 levels were elevated in patients with PE and severe features. Both sFlt-1 and hs-CRP may predict composite adverse maternal outcomes but do not correlate with each other and differ in perinatal morbidity patterns. These data support the hypothesis that the varied outcomes in PE may result from different pathogenic pathways.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000029059","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T13:07:39Z","timestamp":1648732059000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Association of sFlt-1 and C-reactive protein with outcomes in severe preeclampsia"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9006-8823","authenticated-orcid":false,"given":"Leandro","family":"N\u00f3brega","sequence":"first","affiliation":[{"name":"Department of Maternal and Child Health, Instituto de Medicina Integral Prof.Fernando Figueira (IMIP), Recife, Pernambuco, Brazil,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9854-7917","authenticated-orcid":false,"given":"Leila","family":"Katz","sequence":"additional","affiliation":[{"name":"Department of Maternal and Child Health, Instituto de Medicina Integral Prof.Fernando Figueira (IMIP), Recife, Pernambuco, Brazil,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Lippo","sequence":"additional","affiliation":[{"name":"Department of Maternal and Child Health, Instituto de Medicina Integral Prof.Fernando Figueira (IMIP), Recife, Pernambuco, Brazil,Faculdade Pernambucana de Sa\u00fade (FPS), Recife, Pernambuco, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1047-2514","authenticated-orcid":false,"given":"Melania Maria","family":"Amorim","sequence":"additional","affiliation":[{"name":"Department of Maternal and Child Health, Instituto de Medicina Integral Prof.Fernando Figueira (IMIP), Recife, Pernambuco, Brazil,Department of Obstetrics,Universidade Federal de Campina Grande (UFCG), Campina Grande, Para\u00edba,Brazil,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"key":"R1-16-20250504","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of Hypertension Global Hypertension Practice Guidelines.","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"key":"R2-16-20250504","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","article-title":"International Society for the Study of Hypertension in Pregnancy (ISSHP)The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice.","volume":"13","author":"Brown","year":"2018","journal-title":"Pregnancy Hypertens"},{"key":"R3-16-20250504","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12884-021-03809-2","article-title":"Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population-based study.","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"key":"R4-16-20250504","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222.","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R5-16-20250504","doi-asserted-by":"crossref","first-page":"579293","DOI":"10.3389\/fped.2020.579293","article-title":"Neonatal outcome after preeclampsia and HELLP syndrome: a population-based cohort study in Germany.","volume":"8","author":"Bossung","year":"2020","journal-title":"Front Pediatr"},{"key":"R6-16-20250504","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jacc.2020.08.014","article-title":"Preeclampsiapathophysiology and clinical presentations: JACC state-of-the-art review.","volume":"76","author":"Ives","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R7-16-20250504","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41581-019-0119-6","article-title":"Pre-eclampsia: pathogenesis, novel diagnostics and therapies.","volume":"15","author":"Phipps","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"R8-16-20250504","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/s41440-021-00647-9","article-title":"Unravelling the potential of angiogenic factors for the early prediction of preeclampsia.","volume":"44","author":"Deshpande","year":"2021","journal-title":"Hypertens Res"},{"key":"R9-16-20250504","doi-asserted-by":"crossref","first-page":"3864941","DOI":"10.1155\/2020\/3864941","article-title":"The role of inflammation in the pathogenesis of preeclampsia.","volume":"2020","author":"Michalczyk","year":"2020","journal-title":"Mediators Inflamm"},{"key":"R10-16-20250504","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/uog.17373","article-title":"STEPS investigatorssFlt-1\/PlGF for prediction of early-onset pre-eclampsia: STEPS (study of early pre-eclampsia in Spain).","volume":"50","author":"Perales","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R11-16-20250504","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/AOG.0000000000004149","article-title":"Biomarkers and the prediction of adverse outcomes in preeclampsia: a systematic review and meta-analysis.","volume":"137","author":"Lim","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R12-16-20250504","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(10)61351-7","article-title":"PIERS Study GroupPrediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model.","volume":"377","author":"von Dadelszen","year":"2011","journal-title":"Lancet"},{"key":"R13-16-20250504","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ijgo.12197","article-title":"Validation of fullPIERS model for prediction of adverse outcomes among women with severe preeclampsia.","volume":"138","author":"Almeida","year":"2017","journal-title":"Int J Gynaecol Obstet"},{"key":"R14-16-20250504","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0022-3476(67)80066-0","article-title":"A practical classification of newborn infants by weight and gestational age.","volume":"71","author":"Battaglia","year":"1967","journal-title":"J Pediatr"},{"key":"R15-16-20250504","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/ije\/26.1.224","article-title":"The role of conceptual frameworks in epidemiological analysis: a hierarchical approach.","volume":"26","author":"Victora","year":"1997","journal-title":"Int J Epidemiol"},{"key":"R16-16-20250504","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11906-020-01099-1","article-title":"Preeclampsia and kidney disease: deciphering cause and effect.","volume":"22","author":"Kattah","year":"2020","journal-title":"Curr Hypertens Rep"},{"key":"R17-16-20250504","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12884-021-03761-1","article-title":"Comparison of maternal and neonatal outcomes between acute fatty liver of pregnancy and hemolysis, elevated liver enzymes and low platelets syndrome: a retrospective cohort study.","volume":"21","author":"Ang","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"key":"R18-16-20250504","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12884-021-03564-4","article-title":"Mild thrombocytopenia indicating maternal organ damage in pre-eclampsia: a cross-sectional study.","volume":"21","author":"Mayama","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"key":"R19-16-20250504","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ijgo.13370","article-title":"Can pre-eclampsia explain higher cesarean rates in the different groups of Robson\u2019s classification?","volume":"152","author":"Sanchez","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"R20-16-20250504","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3389\/fendo.2020.00655","article-title":"Mechanisms of endothelial dysfunction in pre-eclampsia and gestational diabetes mellitus: windows into future cardiometabolic health?","volume":"11","author":"McElwain","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R21-16-20250504","doi-asserted-by":"crossref","first-page":"S1019","DOI":"10.1016\/j.ajog.2020.10.022","article-title":"Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders.","volume":"226","author":"Rana","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R22-16-20250504","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/HYPERTENSIONAHA.114.04439","article-title":"Neurokinin 3 receptor and phosphocholine transferase: missing factors for pathogenesis of C-reactive protein in preeclampsia.","volume":"65","author":"Parchim","year":"2015","journal-title":"Hypertension"},{"key":"R23-16-20250504","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.biopha.2018.08.122","article-title":"The silencing of ApoC3 suppresses oxidative stress and inflammatory responses in placenta cells from mice with preeclampsia via inhibition of the NF-\u03baB signaling pathway.","volume":"107","author":"Li","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"R24-16-20250504","doi-asserted-by":"crossref","first-page":"dmm035980","DOI":"10.1242\/dmm.035980","article-title":"A double-hit preeclampsia model results in sex-specific growth restriction patterns.","volume":"12","author":"Stojanovska","year":"2019","journal-title":"Dis Model Mech"},{"key":"R25-16-20250504","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/aogs.13978","article-title":"Soluble fms-like tyrosine kinase to placental growth factor ratio in different stages of early-onset fetal growth restriction and small for gestational age.","volume":"100","author":"Garcia-Manau","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R26-16-20250504","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/HYPERTENSIONAHA.120.15146","article-title":"Prediction of preeclampsia-related adverse outcomes with the sFlt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor)-ratio in the clinical routine: a real-world study.","volume":"77","author":"Dr\u00f6ge","year":"2021","journal-title":"Hypertension"},{"key":"R27-16-20250504","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/00365513.2020.1747110","article-title":"C-reactive protein, interleukin-6 and pre-eclampsia: large-scale evidence from the GenPE case-control study.","volume":"80","author":"Serrano","year":"2020","journal-title":"Scand J Clin Lab Invest"},{"key":"R28-16-20250504","first-page":"657","article-title":"Correlation analysis of levels of inflammatory cytokines and nitric oxide in peripheral blood with urine proteins and renal function in patients with gestational hypertension.","volume":"17","author":"Zhang","year":"2019","journal-title":"Exp Ther Med"},{"key":"R29-16-20250504","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/jog.13532","article-title":"Serum amyloid A, procalcitonin, highly sensitive C reactive protein and tumor necrosis factor alpha levels and acute inflammatory response in patients with hemolysis, elevated liver enzymes, low platelet count (HELLP) and eclampsia.","volume":"44","author":"Uckan","year":"2018","journal-title":"J Obstet Gynaecol Res"},{"key":"R30-16-20250504","first-page":"619","article-title":"Evaluation of the predictive value of high sensitivity C-reactive protein in pregnancy-induced hypertension syndrome.","volume":"16","author":"Chen","year":"2018","journal-title":"Exp Ther Med"},{"key":"R31-16-20250504","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/HJH.0000000000002003","article-title":"Ultra-high sensitive C-reactive protein during normal pregnancy and in preeclampsia: a pilot study.","volume":"37","author":"Raio","year":"2019","journal-title":"J Hypertens"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:23:03Z","timestamp":1746332583000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029059"}},"subtitle":["A cohort study"],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":31,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029059","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,18]]},"assertion":[{"value":"2021-08-05 2022-02-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}